Abbott Laboratories (ABT)
NYSE • Currently down 8.31 (-6.87%) in today's trading session
Track congressional stock trades in Abbott Laboratories (ABT). Analyze trading activity from Nancy Pelosi and other members of Congress with real-time financial disclosure data, interactive price charts, and detailed transaction records.
Abbott Laboratories is currently trading at $112.65, positioned at 22% of its 52-week range ($105.27 – $139.06). View which politicians have recently bought or sold ABT and how their trades align with market movements.
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio in real-time with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Not available in the US.
Past Performance is not an indication of future results.
*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.
Abbott Laboratories Price History and Technical Analysis
Congressional Trading Activity for ABT
| Byron Donalds | 04 Dec 2025 | 07 Jan 2026 | Sale | Stock | $1,001 - $15,000 | N/A (Sale Transaction) | |
| Lisa McClain | 10 Jul 2025 | 13 Aug 2025 | Sale | Stock | $1,001 - $15,000 | N/A (Sale Transaction) | |
| Byron Donalds | 20 Mar 2025 | 14 Apr 2025 | Purchase | Stock | $1,001 - $15,000 | -11.59% | |
| Jared Moskowitz | 15 Jan 2025 | 10 Feb 2025 | Sale | Stock | $1,001 - $15,000 | N/A (Sale Transaction) | |
| Jared Moskowitz | 05 Jul 2024 | 19 Aug 2024 | Purchase | Stock | $1,001 - $15,000 | N/A (Price Data Unavailable) |
Select transactions to view their annotations on the chart
Stock Overview
Market Data
Market Cap
$195.73B
Volume
10.67M
Beta
0.74
P/E Ratio
30.20
Fundamentals
EPS
$3.73
Div. Yield
2.13%
Open
$108.94
Day Range
$108.94 — $112.74
Company Information
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NYSE · USD
- Country
- US
- CEO
- Robert Ford
- IPO Date
- 1980-03-17
- Website
- www.abbott.com
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medica...
Earnings
Next Report
Q1 2026
15 Apr
EPS Est.
$1.15
Rev. Est.
$11B
Days Until
36
Recent Quarters
5 politicians traded within 30 days
Dividends
Next Dividend
Ex-Date
15 Apr 2026
Amount
$0.6300 per share
Yield
2.13%
Days Until
36
Dividend History
Stock Splits
Split History
Similar Stocks
Based on congressional trading patterns
Track ABT in Congress
See when politicians buy or sell this stock